Clinical Trial Update: Alfuzosin and Mirabegron for Double-J Stent Symptoms

View source ↗

Summary

A completed clinical trial studied alfuzosin and mirabegron for symptoms related to ureteral (Double-J) stents.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ureteral Stent-related Symptoms

Drugs mentioned

• Myrbetriq (mirabegron)
• Uroxatral (Alfuzosin)

Snippet

Sponsor: University of Gaziantep | Conditions: Ureteral Stent-Related Symptoms | Status: COMPLETED